China Shineway Pharmaceutical Posts About 28% Higher H1 Profit

MT Newswires Live2024-08-29

China Shineway Pharmaceutical Group (HKG:2877) reported a profit attributable to the owners of 626.6 million yuan for the six months ended June 30, a 27.5% increase compared with 491.5 million yuan, according to a Thursday filing with the Hong Kong bourse.

The earnings per share were 0.83 yuan, compared with 0.65 yuan in the year-ago period.

Revenue for the half was 2.09 billion yuan, compared with 2.40 billion yuan in the previous year.

The pharmaceutical announced a second interim dividend of 0.11 yuan per share apart from the first interim dividend of 0.43 yuan.

The company's stocks were up by over 7% at the end of trading.

Price (HKD): $8.75, Change: $+0.69, Percent Change: +8.56%

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2463400151?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2024-08-29 16:24","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2463400151","market":"us","top_or_hot":-1,"title":"China Shineway Pharmaceutical Posts About 28% Higher H1 Profit","media":"MT Newswires Live","content":"<html><body><p> China Shineway Pharmaceutical Group (HKG:2877) reported a profit attributable to the owners of 626.6 million yuan for the six months ended June 30, a 27.5% increase compared with 491.5 million yuan, according to a Thursday filing with the Hong Kong bourse.</p><p>The earnings per share were 0.83 yuan, compared with 0.65 yuan in the year-ago period.</p><p>Revenue for the half was 2.09 billion yuan, compared with 2.40 billion yuan in the previous year.</p><p>The pharmaceutical announced a second interim dividend of 0.11 yuan per share apart from the first interim dividend of 0.43 yuan.</p><p>The company's stocks were up by over 7% at the end of trading.</p><p>Price (HKD): $8.75, Change: $+0.69, Percent Change: +8.56%</p></body></html>","source":"mtnewswires_news","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>China Shineway Pharmaceutical Posts About 28% Higher H1 Profit</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nChina Shineway Pharmaceutical Posts About 28% Higher H1 Profit\n</h2>\n\n<h4 class=\"meta\">\n\n\n2024-08-29 16:24 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.mtnewswires.com/><strong>MT Newswires Live</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>China Shineway Pharmaceutical Group (HKG:2877) reported a profit attributable to the owners of 626.6 million yuan for the six months ended June 30, a 27.5% increase compared with 491.5 million yuan, ...</p>\n\n<a href=\"https://www.mtnewswires.com/\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK4023","symbol_name":"应用软件","start_time":0,"source_url":"https://www.mtnewswires.com/","article_id":"2463400151","we_media_id":"1092851196","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2463400151","pubTimestamp":1724919860,"columns":[],"sourceInfo":{"source_id":"mtnewswires_news","name":"MT Newswires"},"weMediaInfo":{"media_name":"MT Newswires Live","introduction":"The most recognized names in North America, Europe and Asia rely on MT Newswires to power their applications. Better news, better service, better price.","home_visible":1,"id":"1092851196","head_image":"https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e"},"summary":"China Shineway Pharmaceutical Group  reported a profit attributable to the owners of 626.6 million yuan for the six months ended June 30, a 27.5% increase compared with 491.5 million yuan, according to a Thursday filing with the Hong Kong bourse.The earnings per share were 0.83 yuan, compared with 0.65 yuan in the year-ago period.Revenue for the half was 2.09 billion yuan, compared with 2.40 billion yuan in the previous year.The pharmaceutical announced a second interim dividend of 0.11 yuan per share apart from the first interim dividend of 0.43 yuan.The company's stocks were up by over 7% at the end of trading.Price : $8.75, Change: $+0.69, Percent Change: +8.56%","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK4023":"应用软件","HKD":"尚乘数科","BK1191":"制药","BK4585":"ETF&股票定投概念","BK1606":"中医药概念","BK4526":"热门中概股","02877":"神威药业","BK4588":"碎股"},"translate_title":"神威药业上半年利润增长约28%","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"HKD":1,"02877":0.9},"content_text":"China Shineway Pharmaceutical Group (HKG:2877) reported a profit attributable to the owners of 626.6 million yuan for the six months ended June 30, a 27.5% increase compared with 491.5 million yuan, according to a Thursday filing with the Hong Kong bourse.The earnings per share were 0.83 yuan, compared with 0.65 yuan in the year-ago period.Revenue for the half was 2.09 billion yuan, compared with 2.40 billion yuan in the previous year.The pharmaceutical announced a second interim dividend of 0.11 yuan per share apart from the first interim dividend of 0.43 yuan.The company's stocks were up by over 7% at the end of trading.Price (HKD): $8.75, Change: $+0.69, Percent Change: +8.56%","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.30.0","shortVersion":"4.30.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2463400151"}